ALACHUA, FL--(Marketwire - May 16, 2008) - Oragenics, Inc. (d/b/a ONI BioPharma Inc.) (AMEX: ONI) today reported it had received notice from the American Stock Exchange (“AMEX”) advising the Company that it does not meet certain of the listing standards as set forth in part 10 of the AMEX Company Guide.
